The Los Angeles Post
California & Local U.S. World Business Lifestyle
Today: January 24, 2025
Today: January 24, 2025

First over-the-counter birth control pill in US begins shipping to stores

Birth Control Pill
March 04, 2024

WASHINGTON (AP) — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company's suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

First over-the-counter birth control pill in US begins shipping to stores
Birth Control Pill

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Related

Health|Political|US

Trump ends US security for Fauci, the latest ex-official to lose protection

President Donald Trump said on Friday Dr.

Trump ends US security for Fauci, the latest ex-official to lose protection
Health|Political|US

Trump has pulled Fauci’s security detail, source says

Trump has pulled Fauci’s security detail, source says

Trump has pulled Fauci’s security detail, source says
Health|Political|US

Trump defends decision to pull Dr. Fauci's security detail

During a news conference in Fletcher, North Carolina, President Trump was asked about his decision to remove Dr. Anthony Fauci's government-funded security detail. Fauci continues to face threats over his public-facing role during the Covid-19 pandemic, and has now hired private security, a source tells CNN's Kaitlan Collins.

Trump defends decision to pull Dr. Fauci's security detail
Business|Health|Political|US

Trump administration withdraws FDA plan to ban menthol cigarettes

The Trump administration has withdrawn a plan to ban menthol cigarettes in the U.S., in a setback to health regulators and activists.

Trump administration withdraws FDA plan to ban menthol cigarettes
Share This

Popular

Health|Political|US

US FDA drops web pages on improving clinical trial diversity

US FDA drops web pages on improving clinical trial diversity
Health|US

Sergeant Major at Winn Army Hospital overcomes cancer, inspires with resilience and leadership

Sergeant Major at Winn Army Hospital overcomes cancer, inspires with resilience and leadership
Health|Political|US

Trump administration withdraws proposed menthol ban

Trump administration withdraws proposed menthol ban
Business|Finance|Health|Political|US

US drops appeal in case over UnitedHealth Medicare plans' rating

US drops appeal in case over UnitedHealth Medicare plans' rating